Biochemistry Quiz: Protein Function Binding Sites Allostery Specificity

What this quiz covers

This quiz focuses on Protein Function Binding Sites Allostery Specificity, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Molecule M is a competitive inhibitor of Ligand L binding.
2. Molecule M is a positive allosteric modulator of Protein P. (correct answer)
3. Molecule M is a chemical denaturant that unfolds Protein P.
4. Molecule M is a negative allosteric modulator of Protein P.

Explanation: Molecule M causes the Kd for Ligand L to decrease significantly (from 100 μM to 5 μM). A lower Kd signifies higher binding affinity. Since Molecule M binds at a site distinct from the ligand binding site and positively influences ligand binding, it is by definition a positive allosteric modulator (or allosteric activator). It is not a competitive inhibitor because it binds at a different site and increases affinity. It is not a negative modulator because it increases affinity. It is not a denaturant, as that would abolish specific binding.

Question 2

1. F2,6BP binds directly in the active site, acting as a cofactor that properly orients the substrate for catalysis.
2. F2,6BP covalently modifies a key serine residue on PFK-1, leading to a permanent increase in its catalytic efficiency.
3. F2,6BP binds to a regulatory site distinct from the active site, inducing a conformational change that stabilizes the high-affinity R-state. (correct answer)
4. F2,6BP competes with the inhibitor ATP at the substrate-binding site, thereby relieving inhibition and increasing the net reaction rate.

Explanation: Allosteric regulators function by binding to a site separate from the active (substrate-binding) site. This binding event triggers a conformational change that alters the protein's activity. For PFK-1, F2,6BP binds to an allosteric site and stabilizes the R-state (relaxed, high-activity, high-affinity for its substrate F6P), shifting the T/R equilibrium. It is not a cofactor, does not form a covalent bond, and while it does overcome ATP inhibition, it does so via the allosteric mechanism, not by direct competition at the substrate site.

Question 3

1. It allows the enzyme to bind a much wider variety of substrates than a rigid lock-and-key model would permit.
2. It maximizes the initial binding energy with the substrate before any conformational change occurs.
3. It ensures high specificity by forming optimal transition-state stabilizing interactions only after the correct substrate is bound. (correct answer)
4. It permanently alters the enzyme's structure after one catalytic cycle, acting as a form of long-term regulation.

Explanation: The induced-fit model proposes that the enzyme's active site is flexible and changes shape to best accommodate the substrate. A key advantage is that the final, highly active conformation is only achieved with the correct substrate. This process of conformational change positions catalytic groups correctly and stabilizes the reaction's transition state, which is a major source of catalytic power and specificity. It prevents the enzyme from wasting catalytic effort on incorrect substrates. The change is reversible, not permanent.

Question 4

1. ZM binds directly to Substrate-P, altering its shape to become a better fit for the kinase's rigid active site.
2. ZM binding induces a conformational change that simultaneously realigns catalytic residues and reshapes the substrate-binding pocket. (correct answer)
3. ZM binding causes the dissociation of an inhibitory subunit, which simply unmasks a pre-formed, highly specific active site.
4. ZM acts as a scaffold, binding to both the kinase and Substrate-P simultaneously to bring them together in the correct orientation.

Explanation: Allosteric regulation involves conformational changes that propagate through a protein's structure. A single binding event can trigger a complex rearrangement. In this case, the binding of ZM to its regulatory site can cause a shift that (1) moves catalytic residues into a more optimal position for phosphoryl transfer (increasing kcat) and (2) alters the active site's shape and chemical environment to favor unique contacts with Substrate-P and disfavor contacts with other proteins (increasing specificity). This integrated change is a hallmark of sophisticated allosteric control.

Question 5

1. The binding of the first ligand molecule to one subunit increases the ligand affinity of the remaining unoccupied subunits. (correct answer)
2. The protein exists exclusively in either a low-affinity T-state or a high-affinity R-state, with no hybrid intermediates.
3. The binding of a heterotropic allosteric effector molecule is required to initiate the cooperative binding of the ligand.
4. Each of the four binding sites has an intrinsically higher affinity for the ligand than a related monomeric protein would.

Explanation: Positive cooperativity is a form of homotropic allostery defined by the binding of a ligand to one site on a multi-subunit protein, which induces a conformational change that increases the binding affinity of the other sites for the same ligand. This communication between subunits is the core of cooperativity. The other options are incorrect: B describes the concerted (MWC) model but not a necessary consequence of cooperativity itself (sequential models exist), C describes heterotropic, not homotropic, regulation, and D is false as the individual subunits in the unliganded (T) state typically have low affinity.

Question 6

1. A planar aromatic ring structure with several polar hydroxyl groups attached.
2. A short, bulky hydrocarbon group and a terminal carboxylate group.
3. A rigid, cage-like adamantane structure with no charged functional groups.
4. A long, hydrophobic alkyl chain and a terminal, positively charged amino group. (correct answer)

Explanation: A potent and specific inhibitor should maximize favorable interactions with the binding site. The long, hydrophobic chain would fit into the narrow, hydrophobic pocket via van der Waals interactions. The terminal, positively charged amino group would form a strong, favorable salt bridge (ionic interaction) with the negatively charged aspartate residue at the bottom of the pocket. This combination of interactions confers both high affinity and specificity.

Question 7

1. The dissociation constant (Kd) for the ligand will significantly increase, indicating weaker binding. (correct answer)
2. The Kd for the ligand will significantly decrease, reflecting a much higher binding affinity.
3. The maximum velocity (Vmax) of the reaction catalyzed by the protein will decrease, but the Kd will remain unchanged.
4. The protein will now bind a broader range of non-polar ligands, increasing its promiscuity but not affecting its original ligand affinity.

Explanation: Lysine is positively charged at physiological pH and likely forms a critical salt bridge with the negatively charged ligand. Replacing it with alanine, a small, nonpolar amino acid, removes this favorable electrostatic interaction. The loss of this key interaction dramatically weakens the binding affinity, which is reflected as a large increase in the dissociation constant (Kd). Vmax relates to catalysis, not directly to initial binding affinity. A decrease in Kd means stronger binding. While specificity might be altered, the primary and most direct effect is on the affinity for the original ligand.

Question 8

1. Kinase B has both higher affinity and higher specificity for Protein X than Kinase A.
2. Kinase A has both higher affinity and higher specificity for Protein X than Kinase B.
3. Kinase A exhibits higher affinity for Protein X, but Kinase B exhibits higher substrate specificity. (correct answer)
4. The difference in activity is due to Kinase B having a much higher kcat, compensating for its lower affinity for Protein X.

Explanation: Affinity is inversely related to the dissociation constant (Kd). A lower Kd means higher affinity. Therefore, Kinase A (Kd=10 nM) has a higher affinity for Protein X than Kinase B (Kd=500 nM). Specificity refers to the ability to discriminate between different potential substrates. Since Kinase B only phosphorylates Protein X while Kinase A acts on three different proteins, Kinase B is more specific. No information about kcat is given.

Question 9

1. CTP binds competitively at the active site on the catalytic subunits, directly blocking the binding of the substrate aspartate.
2. CTP binds to the regulatory subunits, which stabilizes the low-activity, low-substrate-affinity T-state conformation of the enzyme. (correct answer)
3. CTP forms a covalent bond with a residue in the active site, irreversibly inactivating the catalytic subunits of the enzyme.
4. CTP binds to the substrate aspartate in solution, sequestering it and reducing its effective concentration available to the enzyme.

Explanation: ATCase has distinct catalytic and regulatory subunits. The allosteric inhibitor CTP binds to the regulatory subunits, not the active site. This binding event transmits a conformational change across the protein complex that stabilizes the tense (T) state. The T-state has lower affinity for the substrates (aspartate and carbamoyl phosphate), thus reducing the overall reaction rate. This is a classic example of feedback inhibition via heterotropic allosteric regulation.

Question 10

1. A complete halt in glycogenolysis because the enzyme, though mutated, can no longer bind its substrate, glycogen.
2. Massive accumulation of glycogen because the enzyme is unable to be activated by its allosteric activator, AMP.
3. Uncontrolled glycogenolysis, leading to depletion of glycogen stores and excessive glucose release even in a well-fed state. (correct answer)
4. The rate of glycogenolysis would be regulated solely by substrate availability, with no major ill effects on the cell's energy state.

Explanation: Glycogen phosphorylase breaks down glycogen. Its activity is tightly regulated to occur during fasting/energy demand and be shut off during energy abundance (inhibited by ATP, G6P). A constitutively active mutant would ignore these 'stop' signals. In the liver, this would lead to continuous breakdown of glycogen and release of glucose into the blood, even when blood glucose is high, which is metabolically wasteful and can lead to hyperglycemia.

Question 11

1. The mutant will still display sigmoidal kinetics but with a much higher maximal velocity (Vmax).
2. The mutant will display hyperbolic (Michaelis-Menten) kinetics, and its apparent Km will be relatively high. (correct answer)
3. The mutant will be completely inactive because quaternary structure is essential for catalysis.
4. The mutant will display hyperbolic kinetics with a much lower apparent Km than the wild-type enzyme.

Explanation: Sigmoidal kinetics are a hallmark of cooperativity, which requires communication between subunits. By disrupting the dimer interface, the mutation prevents this communication, so the subunits behave as independent monomers. An individual monomer follows Michaelis-Menten kinetics, producing a hyperbolic curve. Since communication allowing the shift from the low-affinity T-state to the high-affinity R-state is lost, the monomers will likely exhibit the low-affinity characteristics of the T-state, resulting in a relatively high apparent Km.

Question 12

1. D-mannose is a five-membered furanose ring in solution, while D-glucose is a six-membered pyranose ring.
2. The axial position of the hydroxyl group at C2 of mannose sterically hinders the induced-fit conformational change of the enzyme. (correct answer)
3. D-mannose cannot form the critical hydrogen bond with a key aspartate residue that the C4 hydroxyl of glucose forms.
4. The anomeric carbon of D-mannose is locked in the beta configuration, which the enzyme's active site cannot accommodate.

Explanation: Specificity arises from precise interactions. For hexokinase and glucose, the equatorial position of the C2 hydroxyl allows a perfect fit and facilitates the induced-fit clamping motion. In mannose, the C2 hydroxyl is axial. This minor change is enough to create a steric clash or disrupt a key interaction within the active site, preventing the enzyme from adopting its fully active conformation. This slows down catalysis. The other options are factually incorrect: both are primarily pyranoses, the difference is at C2 not C4, and mannose anomerizes freely.

Question 13

1. The enzyme will be fully active because activators always override the effects of inhibitors at the same site.
2. The enzyme will be completely inactive because inhibitors always have a dominant effect over activators.
3. The activity will be exactly half-maximal, as the effects of the activator and inhibitor will cancel each other out.
4. The activity will depend on the relative binding affinities (Kd) of A and I for the regulatory site. (correct answer)

Explanation: Since A and I bind competitively to the same allosteric site, the fractional occupancy of the site by A versus I will determine the enzyme's state. This occupancy is governed by the concentrations of A and I and their respective affinities (inversely related to Kd) for the site. If the affinity for I is much higher than for A, the enzyme will be mostly inhibited, and vice-versa. The activity will reflect this competitive equilibrium, not a fixed rule where one always dominates.

Question 14

1. The valine at position 250 acts as a potent allosteric inhibitor, locking the enzyme in an inactive conformation.
2. The mutation prevents the binding of a necessary metal cofactor at a distant regulatory site on the enzyme's surface.
3. The glycine at position 250 is in a critical turn, and its replacement by bulky valine disrupts the protein's overall tertiary fold. (correct answer)
4. The surface valine residue causes the enzyme to aggregate into inactive amyloid fibrils, which are then cleared by proteolysis.

Explanation: Glycine's small side chain allows it to occupy sterically hindered positions in a protein's structure, such as sharp beta-turns. Replacing it with valine, which has a bulky side chain, can disrupt this critical structural element. This disruption can prevent the entire protein from folding into its correct, stable, and active tertiary structure. The increased susceptibility to proteolysis is a classic indicator of a misfolded or destabilized protein. The loss of activity is therefore a secondary consequence of the loss of structural integrity.

Question 15

1. The second ligand will bind with a Kd2 much greater than 1 nM, which broadens the range of ligand concentrations for a graded response. (correct answer)
2. The second ligand will also bind with a Kd2 of 1 nM, as the two sites are independent and do not influence each other.
3. The second ligand will bind with a Kd2 much less than 1 nM, which sharpens the receptor's response to a narrow ligand concentration range.
4. Binding of the first ligand covalently modifies the second site, preventing any further ligand binding under physiological conditions.

Explanation: Negative cooperativity means the binding of the first ligand induces a conformational change that decreases the affinity of the other site for the ligand. A decrease in affinity corresponds to an increase in the dissociation constant (Kd). Therefore, Kd2 will be significantly larger than Kd1. Physiologically, unlike the switch-like behavior of positive cooperativity, negative cooperativity creates a system that responds gradually over a very wide range of ligand concentrations, providing robustness against small fluctuations.

Question 16

1. The additional hydroxyl group creates unfavorable steric clashes with the substrate during the binding process
2. The mutation disrupts a hydrogen bonding network that maintains optimal geometry for the catalytic mechanism (correct answer)
3. The increased polarity of tyrosine alters the local electrostatic environment and destabilizes the enzyme-substrate complex
4. The larger side chain of tyrosine blocks access to the active site and prevents substrate entry into the binding pocket

Explanation: Since substrate binding is unaffected but catalysis is impaired, the mutation must disrupt catalytic geometry rather than substrate recognition. The 15 Å distance suggests an allosteric effect on active site organization. Choice A would affect binding affinity. Choice C would also affect binding. Choice D would dramatically reduce binding affinity.

Question 17

1. The co-activator competes with inhibitory factors that normally prevent DNA binding at low activator concentrations
2. The co-activator stabilizes the DNA structure and makes it more accessible for binding by the transcriptional activator
3. The co-activator induces a conformational change in the activator that increases its intrinsic DNA binding affinity
4. The co-activator binds to DNA adjacent to the activator and increases the local effective concentration through protein-protein interactions (correct answer)

Explanation: When you encounter questions about cooperative binding in transcriptional regulation, focus on how protein-protein interactions can dramatically enhance DNA binding affinity through proximity effects. The dramatic shift in binding behavior—from requiring 100 nM activator for 90% occupancy to achieving the same occupancy at just 5 nM when the co-activator is present—indicates true cooperative binding. This occurs when the co-activator binds to an adjacent DNA site and forms stabilizing protein-protein interactions with the transcriptional activator. These interactions effectively increase the local concentration of the activator near its binding site, making it much more likely to bind and remain bound to DNA. Option A is incorrect because competition with inhibitory factors would show a more gradual relief of inhibition, not the sharp cooperative effect observed. Option B incorrectly focuses on DNA structural changes rather than protein-protein interactions—the DNA accessibility would affect both conditions equally. Option C suggests the co-activator changes the activator's intrinsic binding properties, but true cooperative binding involves intermolecular interactions between proteins already bound to DNA, not conformational changes that alter intrinsic affinity. The key study tip: Cooperative binding typically involves multiple proteins binding to adjacent sites and stabilizing each other through direct protein-protein contacts. Look for dramatic shifts in binding curves (like the 20-fold improvement here from 100 nM to 5 nM) as a hallmark of cooperativity, and remember that proximity effects through protein-protein interactions are the most common mechanism in transcriptional regulation.

Question 18

1. Effector X promotes cooperative subunit interactions and positive allosteric effects, while effector Y acts as a competitive inhibitor
2. Effector X induces negative cooperativity between subunits, while effector Y stabilizes the active conformation without affecting cooperativity
3. Effector X promotes positive cooperativity and increases intrinsic activity, while effector Y decreases intrinsic activity without inducing cooperativity (correct answer)
4. Both effectors bind to the same allosteric site but induce different conformational changes that affect substrate binding affinity

Explanation: Effector X converts hyperbolic to sigmoidal kinetics (indicating positive cooperativity) and increases activity. Effector Y decreases activity but maintains hyperbolic kinetics (no cooperativity change). Choice A incorrectly calls Y competitive. Choice B incorrectly describes X as negative cooperativity. Choice D doesn't explain the different kinetic patterns.

Question 19

1. 10 μM, because dimerization creates cooperative binding sites that increase the apparent affinity proportionally
2. 50 μM, because the apparent affinity reflects the average of monomer and dimer binding contributions
3. 100 μM, because the intrinsic binding affinity of each subunit remains unchanged regardless of the quaternary structure (correct answer)
4. 200 μM, because the energy cost of maintaining the dimeric structure reduces the available binding energy

Explanation: The intrinsic $K_d$ of each subunit for substrate remains 100 μM regardless of whether the protein is monomeric or dimeric. The increased dimer stability affects protein-protein interactions, not substrate binding affinity. The apparent $K_d$ for substrate binding to individual sites doesn't change. Choices A and B incorrectly link dimerization to substrate affinity. Choice D incorrectly suggests energetic coupling reduces binding.

Question 20

1. A hydrophobic pocket that accommodates the methyl group present in substrate A but creates steric clashes with substrate B
2. An electrostatic interaction network that specifically recognizes the charge distribution pattern shared by substrates A and B
3. A shape complementarity requirement that strongly favors substrate A, partially accommodates B, but cannot bind the bulkier substrate C
4. A hydrogen bonding pattern that is optimized for substrate A, partially satisfied by B, but disrupted by the charged group in C (correct answer)

Explanation: The 50-fold difference between A and B (single methyl group) suggests specific hydrogen bonding that's disrupted by the methyl substitution. Complete loss of binding to C indicates the charged amino group is incompatible, likely disrupting the hydrogen bonding network. Choice A would favor B over A. Choice B doesn't explain A vs B difference. Choice C doesn't account for the charge effect.